IP Library Granted Patent US 1,109,621
Granted Patent S1
US 1,109,621 · App. 29/937,490 · Granted Jan 20, 2026

Analytical platform for biological material testing

Inventors: John Cesarek (Redwood City, CA); Treasure L. Hinds (Issaquah, WA); Gregory T. Janky (Sammamish, WA); Albert C. Winsman (Arvada, CO)
Assignee: Cellares Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 1,109,621
App. No.
29/937,490
Granted
Jan 20, 2026
Kind
S1
Claims (1)

The ornamental design for an analytical platform for biological material testing, as shown and described.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2024
From: ANVIL STUDIOS, INC.
To: CELLARES CORPORATION
Reel/Frame 068594/0374 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2024
From: CESAREK, JOHN; WINSMAN, ALBERT C.
To: CELLARES CORPORATION
Reel/Frame 068574/0624 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2024
From: HINDS, TREASURE L.; JANKY, GREGORY T.
To: ANVIL STUDIOS, INC.
Reel/Frame 068574/0662 →
References Cited (284)
US 3728227A · Elson et al. · 1973 [cited by applicant]
US 4234023A · Sogi et al. · 1980 [cited by applicant]
US 4696902A · Bisconte · 1987 [cited by applicant]
US 4751184A · Higo et al. · 1988 [cited by applicant]
US 4839292A · Cremonese · 1989 [cited by applicant]
US 4911833A · Schoendorfer et al. · 1990 [cited by applicant]
US 5058619A · Zheng · 1991 [cited by applicant]
US 5656491A · Cassani et al. · 1997 [cited by applicant]
US 6649419B1 · Anderson · 2003 [cited by applicant]
US 6891182B2 · Watari et al. · 2005 [cited by applicant]
US 7550287B2 · Hibino et al. · 2009 [cited by applicant]
US 7745209B2 · Martin et al. · 2010 [cited by applicant]
US 7816128B2 · Nakashima et al. · 2010 [cited by applicant]
US 8158426B2 · Wilson et al. · 2012 [cited by applicant]
US 8158427B2 · Wilson et al. · 2012 [cited by applicant]
US 8168432B2 · Wilson et al. · 2012 [cited by applicant]
US 8273572B2 · Martin et al. · 2012 [cited by applicant]
US 8415144B2 · Wilson et al. · 2013 [cited by applicant]
US 8440458B2 · Zijlstra et al. · 2013 [cited by applicant]
US 8470589B2 · Martin et al. · 2013 [cited by applicant]
US 8492140B2 · Smith et al. · 2013 [cited by applicant]
US 8546142B2 · Martin et al. · 2013 [cited by applicant]
US D693714S · Noda · 2013 [cited by examiner]
US 8697443B2 · Wilson et al. · 2014 [cited by applicant]
US 8727132B2 · Miltenyi et al. · 2014 [cited by applicant]
US 8809044B2 · Wilson · 2014 [cited by applicant]
US 8846399B2 · Martin et al. · 2014 [cited by applicant]
US 8956860B2 · Vera et al. · 2015 [cited by applicant]
US 9040290B2 · Martin et al. · 2015 [cited by applicant]
US 9045721B2 · Martin et al. · 2015 [cited by applicant]
US 9080149B2 · Bosio et al. · 2015 [cited by applicant]
US 9255243B2 · Wilson et al. · 2016 [cited by applicant]
US 9279099B2 · Okano et al. · 2016 [cited by applicant]
US 9290730B2 · Martin et al. · 2016 [cited by applicant]
US 9410114B2 · Wilson et al. · 2016 [cited by applicant]
US 9441192B2 · Wilson et al. · 2016 [cited by applicant]
US 9499780B2 · Smith et al. · 2016 [cited by applicant]
US 9534195B2 · Smith et al. · 2017 [cited by applicant]
US 9556485B2 · Lin et al. · 2017 [cited by applicant]
US 9567565B2 · Vera et al. · 2017 [cited by applicant]
US 9597355B2 · Magnant · 2017 [cited by applicant]
US 9625463B2 · Miltenyi et al. · 2017 [cited by applicant]
US 9701932B2 · Smith et al. · 2017 [cited by applicant]
US 9732317B2 · Wilson · 2017 [cited by applicant]
US D799999S · Barton · 2017 [cited by examiner]
US 9783768B2 · Larcher et al. · 2017 [cited by applicant]
US 9845451B2 · Martin et al. · 2017 [cited by applicant]
US 10047342B2 · Eibl et al. · 2018 [cited by applicant]
US 10053663B2 · Kabaha et al. · 2018 [cited by applicant]
US 10119970B2 · Miltenyi et al. · 2018 [cited by applicant]
US 10131876B2 · Kaiser et al. · 2018 [cited by applicant]
US D843251S · Barton · 2019 [cited by examiner]
US 10253316B2 · Masquelier et al. · 2019 [cited by applicant]
US 10294658B2 · Scannon et al. · 2019 [cited by applicant]
US 10323258B2 · Bernate et al. · 2019 [cited by applicant]
US 10329559B1 · Masquelier et al. · 2019 [cited by applicant]
US 10385307B2 · Rowley et al. · 2019 [cited by applicant]
US 10421959B1 · Masquelier et al. · 2019 [cited by applicant]
US 10508288B1 · Bernate et al. · 2019 [cited by applicant]
US 10519437B1 · Masquelier et al. · 2019 [cited by applicant]
US 10533156B2 · Vera et al. · 2020 [cited by applicant]
US 10584333B1 · Masquelier et al. · 2020 [cited by applicant]
US 10584334B1 · Masquelier et al. · 2020 [cited by applicant]
US 10588994B2 · Kawamura et al. · 2020 [cited by applicant]
US 10620212B2 · Miltenyi et al. · 2020 [cited by applicant]
US 10689669B1 · Feldman et al. · 2020 [cited by applicant]
US 10705090B2 · Miltenyi et al. · 2020 [cited by applicant]
US 10705091B2 · Miltenyi et al. · 2020 [cited by applicant]
US 10723986B2 · Smith et al. · 2020 [cited by applicant]
US 10724043B2 · Sixto et al. · 2020 [cited by applicant]
US 10844338B1 · Smith et al. · 2020 [cited by applicant]
US 11161111B2 · Kabaha et al. · 2021 [cited by applicant]
US 11198845B2 · Parietti et al. · 2021 [cited by applicant]
US 11371018B2 · Shi et al. · 2022 [cited by applicant]
US 11376587B2 · Thakkar et al. · 2022 [cited by applicant]
US 11447745B2 · Shi et al. · 2022 [cited by applicant]
US D992081S · McKelvie · 2023 [cited by examiner]
US 11701654B2 · Azersky et al. · 2023 [cited by applicant]
US 11786896B2 · Thakkar et al. · 2023 [cited by applicant]
US 11826756B2 · Azersky et al. · 2023 [cited by applicant]
US 11872557B2 · Biz et al. · 2024 [cited by applicant]
US D1020502S · Kang · 2024 [cited by examiner]
US 12157119B2 · Gerlinghaus et al. · 2024 [cited by applicant]
US 12180453B2 · Chang et al. · 2024 [cited by applicant]
US D1074480S · Pilko · 2025 [cited by examiner]
US 12305156B2 · Burkeen et al. · 2025 [cited by applicant]
US 12337321B2 · Malleo et al. · 2025 [cited by applicant]
US 12350664B2 · Pesch et al. · 2025 [cited by applicant]
US 12350667B2 · Azersky et al. · 2025 [cited by applicant]
US 12350668B2 · Azersky et al. · 2025 [cited by applicant]
US 20030030272A1 · Johnson et al. · 2003 [cited by applicant]
US 20030031542A1 · Hamel et al. · 2003 [cited by applicant]
US 20060194193A1 · Tsuruta et al. · 2006 [cited by applicant]
US 20060257999A1 · Chang et al. · 2006 [cited by applicant]
US 20070185472A1 · Baumfalk et al. · 2007 [cited by applicant]
US 20080057568A1 · Kan et al. · 2008 [cited by applicant]
US 20080176318A1 · Wilson et al. · 2008 [cited by applicant]
US 20090042281A1 · Chang et al. · 2009 [cited by applicant]
US 20090247417A1 · Haas et al. · 2009 [cited by applicant]
US 20110003380A1 · Miltenyi et al. · 2011 [cited by applicant]
US 20110223064A1 · Katsumi et al. · 2011 [cited by applicant]
US 20110262896A1 · Blecka et al. · 2011 [cited by applicant]
US 20120138156A1 · Hofman et al. · 2012 [cited by applicant]
US 20120283867A1 · Gelbman et al. · 2012 [cited by applicant]
US 20120293338A1 · Chaffey et al. · 2012 [cited by applicant]
US 20130115617A1 · Wilson · 2013 [cited by applicant]
US 20130132006A1 · Gwynn et al. · 2013 [cited by applicant]
US 20140309795A1 · Norton et al. · 2014 [cited by applicant]
US 20150037803A1 · Park et al. · 2015 [cited by applicant]
US 20150224497A1 · Furrer et al. · 2015 [cited by applicant]
US 20150307829A1 · Dedry et al. · 2015 [cited by applicant]
US 20160060680A1 · Buse et al. · 2016 [cited by applicant]
US 20160161516A1 · Fritchie et al. · 2016 [cited by applicant]
US 20160208216A1 · Vera et al. · 2016 [cited by applicant]
US 20160303563A1 · Granier et al. · 2016 [cited by applicant]
US 20160320381A1 · Holmes et al. · 2016 [cited by applicant]
US 20160320422A1 · Fritchie et al. · 2016 [cited by applicant]
US 20170307502A1 · Mason et al. · 2017 [cited by applicant]
US 20170313977A1 · Wilson · 2017 [cited by applicant]
US 20170321226A1 · Gill et al. · 2017 [cited by applicant]
US 20170362554A1 · Martin et al. · 2017 [cited by applicant]
US 20180051243A1 · Hogan et al. · 2018 [cited by applicant]
US 20180078935A1 · Hung et al. · 2018 [cited by applicant]
US 20180196918A1 · Sadowski et al. · 2018 [cited by applicant]
US 20190212233A1 · Jovanovich et al. · 2019 [cited by applicant]
US 20190275519A1 · Castillo et al. · 2019 [cited by applicant]
US 20190292510A1 · Tandon et al. · 2019 [cited by applicant]
US 20190316120A1 · Masquelier et al. · 2019 [cited by applicant]
US 20200025782A1 · Ahlfors · 2020 [cited by applicant]
US 20200095550A1 · Vera et al. · 2020 [cited by applicant]
US 20200159198A1 · Kapre et al. · 2020 [cited by applicant]
US 20200292552A1 · Miltenyi et al. · 2020 [cited by applicant]
US 20200353004A1 · Nowak et al. · 2020 [cited by applicant]
US 20200368411A1 · Camisani et al. · 2020 [cited by applicant]
US 20200406221A1 · Dabrowski et al. · 2020 [cited by applicant]
US 20210032583A1 · Smith et al. · 2021 [cited by applicant]
US 20210047668A1 · Dabrowski et al. · 2021 [cited by applicant]
US 20210079344A1 · Bosio et al. · 2021 [cited by applicant]
US 20210147807A1 · Lickert et al. · 2021 [cited by applicant]
US 20210253997A1 · Wilson · 2021 [cited by applicant]
US 20210269755A1 · Smith et al. · 2021 [cited by applicant]
US 20210283565A1 · Gerlinghaus et al. · 2021 [cited by applicant]
US 20210283606A1 · Thakkar et al. · 2021 [cited by applicant]
US 20210301239A1 · Natsume et al. · 2021 [cited by applicant]
US 20210324318A1 · Parietti et al. · 2021 [cited by applicant]
US 20210354104A1 · Pesch et al. · 2021 [cited by applicant]
US 20220003796A1 · Ahlfors · 2022 [cited by applicant]
US 20220143610A1 · Biz et al. · 2022 [cited by applicant]
US 20220150650A1 · Rucker · 2022 [cited by applicant]
US 20220259546A1 · Blanchard · 2022 [cited by applicant]
US 20220325219A1 · Parietti et al. · 2022 [cited by applicant]
US 20220347683A1 · Thakkar et al. · 2022 [cited by applicant]
US 20230149922A1 · Thakkar et al. · 2023 [cited by applicant]
US 20230321650A1 · Azersky et al. · 2023 [cited by applicant]
US 20230415154A1 · Pesch et al. · 2023 [cited by applicant]
US 20230415155A1 · Biz et al. · 2023 [cited by applicant]
US 20240165613A1 · Azersky et al. · 2024 [cited by applicant]
US 20240254426A1 · Elpel et al. · 2024 [cited by applicant]
US 20240255537A1 · Malleo et al. · 2024 [cited by applicant]
US 20240279588A1 · Malleo et al. · 2024 [cited by applicant]
US 20240318116A1 · Chang et al. · 2024 [cited by applicant]
US 20240326043A1 · Gerlinghaus et al. · 2024 [cited by applicant]
US 20240369586A1 · Tian et al. · 2024 [cited by applicant]
US 20240377420A1 · Cesarek · 2024 [cited by applicant]
US 20240390897A1 · Azersky et al. · 2024 [cited by applicant]
US 20240390898A1 · Azersky et al. · 2024 [cited by applicant]
US 20240399365A1 · Biz et al. · 2024 [cited by applicant]
US 20240402206A1 · Boppart et al. · 2024 [cited by applicant]
US 20250002837A1 · Thakkar et al. · 2025 [cited by applicant]
US 20250059492A1 · Beban et al. · 2025 [cited by applicant]
US 20250065331A1 · Malleo et al. · 2025 [cited by applicant]
US 20250066708A1 · Burkeen et al. · 2025 [cited by applicant]
US 20250066709A1 · Grout et al. · 2025 [cited by applicant]
US 20250129321A1 · Malleo et al. · 2025 [cited by applicant]
US 20250207076A1 · Marchiando et al. · 2025 [cited by applicant]
US 20250236832A1 · Chang et al. · 2025 [cited by applicant]
CN 104203333A · 2014 [cited by applicant]
CN 108660060A · 2018 [cited by applicant]
EP 0246912A2 · 1987 [cited by applicant]
EP 0991389A1 · 2000 [cited by applicant]
EP 0824380B1 · 2002 [cited by applicant]
EP 3134512B1 · 2019 [cited by applicant]
EP 2809449B1 · 2019 [cited by applicant]
EP 3359294B1 · 2020 [cited by applicant]
GB 2268187A · 1994 [cited by applicant]
JP 2007325586A · 2007 [cited by applicant]
KR 20130018286A · 2013 [cited by applicant]
WO WO2006102416A2 · 2006 [cited by applicant]
WO WO2006112870A1 · 2006 [cited by applicant]
WO WO2006118282A1 · 2006 [cited by applicant]
WO WO2007139742A1 · 2007 [cited by applicant]
WO WO2009072003A2 · 2009 [cited by applicant]
WO WO2017041051A1 · 2017 [cited by applicant]
WO WO2017123663A1 · 2017 [cited by applicant]
WO WO2018015561A1 · 2018 [cited by applicant]
WO WO2018102471A1 · 2018 [cited by applicant]
WO WO2019232504A2 · 2019 [cited by applicant]
WO WO2020009700A1 · 2020 [cited by applicant]
WO WO2020014264A1 · 2020 [cited by applicant]
WO WO2021168368A1 · 2021 [cited by applicant]
WO WO2021183687A2 · 2021 [cited by applicant]
WO WO2021212124A1 · 2021 [cited by applicant]
WO WO2024102996A1 · 2024 [cited by applicant]
WO WO2024206703A1 · 2024 [cited by applicant]
WO WO2024233080A1 · 2024 [cited by applicant]
WO WO2024249904A1 · 2024 [cited by applicant]
ChargePoint (2021). Aseptic split butterfly valve 10-6 sterility assurance, located at https://www.thechargepoint.com/products/aseptic-split-butterfly-valve-10-6-sterility-assurance/, 2 total pages. [cited by applicant]
CPC (2014). “6 traits of non-spill: How quick disconnect couplings evolved for low-pressure fluid handling,” White Paper 8004, 4 total pages. [cited by applicant]
CPC (2014). “How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs,” White Paper 7004, 6 total pages. [cited by applicant]
CPC (2018). Comparison Guide: Tube Welders and Aseptic Connectors, Technical Guide 7009, 3 total pages. [cited by applicant]
EMD Millipore (2015). “Lynx® S2S Connector—Low temperature compatibility (−80″C),” 4 total pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/331,554 mailed Aug. 29, 2024, 18 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/731,095 mailed Nov. 26, 2024, 31 pages. [cited by applicant]
Final Office Action mailed on Apr. 28, 2022, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 11 pages. [cited by applicant]
Final Office Action mailed on Apr. 28, 2022, for U.S. Appl. No. 17/331,554, filed May 26, 2021, 16 pages. [cited by applicant]
Final Office Action mailed on Jul. 31, 2023, for U.S. Appl. No. 17/331,554, filed May 26, 2021, 19 pages. [cited by applicant]
Final Office Action mailed on Mar. 31, 2023, for U.S. Appl. No. 17/579,478, filed Jan. 19, 2022, 8 pages. [cited by applicant]
Garcia et al., “Microfluidic Screening of Electric Fields for Electroporation” Sci Rep. Feb. 19, 2016; 6:21238. pages 1-11. [cited by applicant]
Genetic Engineering & Biotechnology News (2006). “Thermal welding for sterile connections,” located at https://www.genengnews.com/magazine/47/thermal-welding-for-sterile-connections/, 5 total pages. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2024/025064 mailed Sep. 6, 2024, 17 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2024/022079 mailed Sep. 12, 2024, 25 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2024/032062 mailed Sep. 6, 2024, 15 pages. [cited by applicant]
International Search Report mailed on Oct. 13, 2021, for PCT Application No. PCT/US2021/021773, filed on Mar. 10, 2021, 13 pages. [cited by applicant]
Invitation to Pay Additional Fees for International Application No. PCT/US2024/022079 dated Jul. 17, 2024, 19 pages. [cited by applicant]
Invitation to Pay Additional fees for International Application No. PCT/US2024/025064, mailed Jul. 16, 2024, 12 pages. [cited by applicant]
Jain, S. et al. (2011). “The complete automation of cell culture: improvements for high-throughput and high-content screening,” J. Biomol. Screen 16:932-939. [cited by applicant]
Kato, R. et al. (2010). “A Compact, Automated Cell Culture System for Clinical Scale Cell Expansion from Primary Tissues,” Tissue Engineering: Part C 16:947-956. [cited by applicant]
Kempner, M.E. and Felder, R.A., “A review of cell culture automation”. JALA: Journal of the Association for Laboratory Automation (Apr. 2002); 7(2): 56-62. [cited by applicant]
Kino-Oka, M. et al. (2005). “Bioreactor Design for Successive Culture of Anchorage-Dependent Cells Operated in an Automated Manner,” Tissue Engineering 11:535-545. [cited by applicant]
Knoll, A. et al. (2004). “Flexible automation of cell culture and tissue engineering tasks,” Biotechnol. Prog. 20:1825-1835. [cited by applicant]
Lutkemeyer, D. et al. (2000). “First steps in robot automation of sampling and sample management during cultivation of mammalian cells in pilot scale,” Biotechnol. Prog. 16:822-828. [cited by applicant]
MEDInstill (2021). INTACT™ Connectors, located at https://www.medinstill.com/intactconnectors.php, 1 total page. [cited by applicant]
Millipore® (2020). “Technical Brief—Choosing the right sterile connector based on design and sterility test results,” 4 total pages. [cited by applicant]
Millipore Sigma (2020). “Lynx® CDR Connectors,” Datasheet, 4 total pages. [cited by applicant]
Millipore Sigma (2021). Lynx® CDR Connectors, located at https://www.emdmillipore.com/US/en/product/Lynx-CDR-Connectors,MM_NF-C188801, 2 total pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/244,051 mailed Oct. 9, 2024, 10 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/638,658 mailed on Nov. 22, 2024, 13 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/731,095 mailed Aug. 8, 2024, 24 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/792,358 mailed on Nov. 6, 2024, 5 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/799,963 mailed Sep. 30, 2024, 9 pages. [cited by applicant]
Non-Final Office Action mailed on Apr. 24, 2024, for U.S. Appl. No. 17/331,554, filed May 26, 2021, 17 pages. [cited by applicant]
Non-Final Office Action mailed on Dec. 22, 2022, for U.S. Appl. No. 17/579,478, filed Jan. 19, 2022, 8 pages. [cited by applicant]
Non-Final Office Action mailed on Dec. 3, 2021, for U.S. Appl. No. 17/331,556, filed May 26, 2021, 9 pages. [cited by applicant]
Non-Final Office Action mailed on Feb. 3, 2022, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 5 pages. [cited by applicant]
Non-Final Office Action mailed on Jun. 26, 2023, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 15 pages. [cited by applicant]
Non-Final Office Action mailed on Mar. 16, 2023, for U.S. Appl. No. 17/331,554, filed May 26, 2021, 16 pages. [cited by applicant]
Non-Final Office Action mailed on Oct. 28, 2021, for U.S. Appl. No. 17/331,554, filed May 26, 2021, 11 pages. [cited by applicant]
Non-Final Office Action mailed on Oct. 6, 2021, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 7 pages. [cited by applicant]
Non-Final Office Action mailed on Sep. 13, 2023, for U.S. Appl. No. 18/141,329, filed Apr. 28, 2023, 7 pages. [cited by applicant]
Notice of Allowance mailed on Apr. 11, 2024, for U.S. Appl. No. 17/198,134, filed Mar. 10, 2021, 9 pages. [cited by applicant]
Notice of Allowance mailed on Jul. 18, 2023, for U.S. Appl. No. 17/849,422, filed Jun. 24, 2022, 8 pages. [cited by applicant]
Notice of Allowance mailed on Jul. 25, 2023, for U.S. Appl. No. 17/579,478, filed Jan. 19, 2022, 8 pages. [cited by applicant]
Notice of Allowance mailed on Jun. 8, 2023, for U.S. Appl. No. 17/849,422, filed Jun. 24, 2022, 8 pages. [cited by applicant]
Notice of Allowance mailed on Mar. 1, 2022, for U.S. Appl. No. 17/331,556, filed May 26, 2021, 8 pages. [cited by applicant]
Notice of Allowance mailed on Mar. 22, 2023, for U.S. Appl. No. 17/992,784, filed Nov. 22, 2022, 8 pages. [cited by applicant]
Notice of Allowance mailed on Oct. 4, 2023, for U.S. Appl. No. 18/141,329, filed Apr. 28, 2023, 8 pages. [cited by applicant]
Pharma Japan, “Astellas Set to Cut Development Time with Cell Culture Robot, Eyes 4 Billion Yen Profit per Product” Aug. 9, 2023, 3 pages. [cited by applicant]
Qu, B. et al., “Droplet Electroporation in Microfluidics for Efficient Cell Transformation with or without Cell Wall Removal,” Lab Chip (2012) 12:4483-4488. [cited by applicant]
Saint Gobain (2017). “Pure-Fit® SC—Secure aseptic connections,” Brochure, 5 total pages. [cited by applicant]
Sartorius Stedim Biotech (2011). “Opta® SFT,” 4 total pages. [cited by applicant]
Schwartz C., “Optimizing Cell Separation with Beckman Coulter's Centrifugal Elutriation System,” Beckmann Coulter Life Sciences (2014) 6 total pages. [cited by applicant]
SeriesLock™ (2021). Features and Specifications, located at https://serieslock.com/, 5 total pages. [cited by applicant]
Shi, Y. et al. (1992). “Performance of Mammalian Cell Culture Bioreactor with a New Impeller Design,” Biotechnology and Bioengineering 40:260-270. [cited by applicant]
Steris (2018). “A compilation of material compatibilities with vaporized hydrogen peroxide,” 2 total pages. [cited by applicant]
Steris (2018). “Sterility assurance levels (SALS): Irradiation,” 3 total pages. [cited by applicant]
Steris (2020). “Overview of sterilization technology comparison,” 1 total page. [cited by applicant]
Strahlendorf, K.A. et al. (2009). “Bio Pharm International—A review of sterile connectors,” vol. 2009 Supplement, Issue 8, located at https://www.biopharminternational.com/view/review-sterile-connectors, 9 total pages. [cited by applicant]
U.S. Appl. No. 18/807,699, filed Aug. 16, 2024, by Beban et al. [cited by applicant]
U.S. Appl. No. 29/898,923, filed Aug. 2, 2023, by Gerlinghaus et al. [cited by applicant]
Written Opinion of the International Searching Authority mailed on Oct. 13, 2021, for PCT Application No. PCT/US2021/021773, filed on Mar. 10, 2021, 20 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/244,051 mailed Apr. 4, 2025, 11 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/638,658 mailed Mar. 14, 2025, 15 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/731,095 mailed Aug. 7, 2025, 35 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/799,963 mailed Jan. 30, 2025, 10 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/731,095 mailed Mar. 6, 2025, 34 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/807,699 mailed Apr. 29, 2025, 19 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/331,554 mailed Apr. 10, 2025, 6 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/331,554 mailed Mar. 5, 2025, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/487,884 mailed Feb. 26, 2025, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/487,884 mailed on Apr. 3, 2025, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/792,358 mailed on Mar. 3, 2025, 8 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/792,360 mailed Mar. 4, 2025, 9 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/792,360 mailed on Jan. 29, 2025, 9 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 18/799,963 mailed Jul. 1, 2025, 7 pages. [cited by applicant]